FNBP1 and cervical carcinoma: The chemosensitization of cervical cancers using traditional drugs in combination with the silencing of FNBP1 were assessed, the outcomes of which guaranteed FNBP1 a promising target for cervical cancers in combination therapy (Figure 6).